BioCentury
ARTICLE | Clinical News

HTERT peptide vaccine: Phase I started

March 7, 2016 8:00 AM UTC

The partners began the open-label, U.K. Phase I VAPER trial to evaluate intradermal hTERT peptide vaccine given every 3 weeks in up to 30 patients. All patients will receive imiquimod and cyclophospha...